A study found that the investigational antiviral mosnodenvir reduced dengue virus infection RNA levels and symptoms in a controlled setting, supporting its potential as a prophylactic option.
Noah Rosenberg, MD
Advertisement
Rosenberg is a fellow in infectious diseases and chief medical resident in internal medicine at Beth Israel Deaconess Medical Center in Boston, Massachusetts.
Articles by Noah Rosenberg, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
The Latest on the Cyclosporiasis Outbreak: An FDA False Positive Test, and What Treatment Looks Like
2
Researching Repurposed Medications for Long COVID
3
Once-Weekly Islatravir/Lenacapavir Meets Phase 3 Primary End Point
4
FDA Accepts Shionogi's sNDA to Expand Cefiderocol Use to Pediatric Patients With Drug-Resistant Gram-Negative Infections
5